Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30 + Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program-Reference-Cited by-同舟云学术

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30 + Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program

Published:2016-01-14 Issue:4 Volume:101 Page:466-473
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Perrot Aurore,Monjanel Hélène,Bouabdallah Réda,Quittet Philippe,Sarkozy Clémentine,Bernard Marc,Stamatoullas Aspasia,Borel Cécile,Bouabdallah Krimo,Nicolas-Virelizier Emmanuelle,Fournier Marion,Morschhauser Franck,Brice Pauline

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort;Blood Advances;2023-10-31

2. Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study;Leukemia & Lymphoma;2022-08-17

3. Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma;International Journal of Hematology;2022-05-05

4. Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy;Cancers;2021-12-05

5. Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma;Transplantology;2021-10-03